Know Cancer

or
forgot password

Vaginal Length, Elasticity, Lubrication And Sexual Function In Women With Stage IB2 Cervix Carcinoma


N/A
N/A
69 Years
Not Enrolling
Female
Cervical Cancer, Sexuality and Reproductive Issues

Thank you

Trial Information

Vaginal Length, Elasticity, Lubrication And Sexual Function In Women With Stage IB2 Cervix Carcinoma


OBJECTIVES:

- Obtain estimates of changes in vaginal length, perceived vaginal elasticity, perceived
vaginal lubrication, and sexual activity, response, and satisfaction among patients
with stage IB2 cervical cancer.

- Compare these differences between the patients in the two treatment groups in GOG-0201.

- Determine the relationships between vaginal dilation activities and vaginal length
changes in these patients.

- Determine the association between smoking and vaginal length and between smoking and
vaginal dryness in these patients after therapy for cervical cancer.

- Assess the extent of subject interest in and preferred methods of sexual counseling
related to problems resulting from treatment in these patients.

OUTLINE: Vaginal length is measured using Vaginal Sound, a modified plastic vaginal dilator.
The data about vaginal elasticity and lubrication and sexual activity, response, and
satisfaction are obtained from patient self-report, as well as vaginal dilation activities.
Measurement and assessments are taken before treatment and then at 3, 6, 12, and 24 months.

Patients are followed every 3 months for 2 years.

PROJECTED ACCRUAL: Approximately 150 patients will be accrued for this study.

Inclusion Criteria


DISEASE CHARACTERISTICS:

- Entered and treated on GOG-0201 or eligible for and treated on either arm of GOG-0201

- May have refused entry on GOG-0201 as long as treatment is prescribed according
to one or the other arm

PATIENT CHARACTERISTICS:

Age

- Under 70

Performance status

- Not specified

Life expectancy

- Not specified

Hematopoietic

- Not specified

Hepatic

- Not specified

Renal

- Not specified

PRIOR CONCURRENT THERAPY:

Biologic therapy

- Not specified

Chemotherapy

- Not specified

Endocrine therapy

- Not specified

Radiotherapy

- Not specified

Surgery

- Not specified

Type of Study:

Observational

Study Design:

N/A

Principal Investigator

Deborah Watkins Bruner, RN, PhD

Investigator Role:

Study Chair

Investigator Affiliation:

Fox Chase Cancer Center

Authority:

United States: Federal Government

Study ID:

CDR0000269327

NCT ID:

NCT00053261

Start Date:

July 2003

Completion Date:

Related Keywords:

  • Cervical Cancer
  • Sexuality and Reproductive Issues
  • sexuality and reproductive issues
  • stage IB cervical cancer
  • Uterine Cervical Neoplasms

Name

Location

Abington Memorial HospitalAbington, Pennsylvania  19001
Bronson Methodist HospitalKalamazoo, Michigan  49007
West Michigan Cancer CenterKalamazoo, Michigan  49007-3731
Borgess Medical CenterKalamazooaa, Michigan  49001
Ellis Fischel Cancer Center at University of Missouri - ColumbiaColumbia, Missouri  65203
Long Island Cancer Center at Stony Brook University HospitalStony Brook, New York  11790-7775
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel HillChapel Hill, North Carolina  27599-7570
Oklahoma University Medical CenterOklahoma City, Oklahoma  73104
Cancer Care Associates - Midtown TulsaTulsa, Oklahoma  74104
Curtis & Elizabeth Anderson Cancer Institute at Memorial Health University Medical CenterSavannah, Georgia  31403-3089
SUNY Upstate Medical University HospitalSyracuse, New York  13210
John and Dorothy Morgan Cancer Center at Lehigh Valley HospitalAllentown, Pennsylvania  18105